Search Results - "Eriksson, JK"

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? by Eriksson, Jonas K, Jacobsson, Lennart, Bengtsson, Karin, Askling, Johan

“…To assess and compare the incidence of cardiovascular (CV) events, by CV phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis…”
Get more information

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab by Neovius, M, Arkema, E V, Olsson, H, Eriksson, J K, Kristensen, L E, Simard, J F, Askling, J

“…To compare drug survival on adalimumab, etanercept and infliximab in patients with rheumatoid arthritis (RA). Patients with RA (n=9139; 76% women; mean age 56…”
Get more information

Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs? by Eriksson, JK, Anell, B

Get full text

ND2 - Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs? by Eriksson, JK, Anell, B

Get full text

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? by Eriksson, Jonas K, Johansson, Kari, Askling, Johan, Neovius, Martin

“…To estimate the costs related to hospital care, drug use and work loss in prevalent and incident patients with rheumatoid arthritis (RA), and to describe their…”
Get more information

Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County by Waldenlind, Kristin, Eriksson, Jonas K, Grewin, Bernhard, Askling, Johan

“…The Swedish National Patient Register offers unique possibilities for identification of large cohorts, such as patients with rheumatoid arthritis (RA)…”
Get full text

Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population‐Based Assessment of Incidence, Its Determinants, and Treatment Penetration by Eriksson, Jonas K., Neovius, Martin, Ernestam, Sofia, Lindblad, Staffan, Simard, Julia F., Askling, Johan

“…Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden, including its variation across age, sex, geography, and demography, and…”
Get full text

The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data by Eriksson, JK, Askling, J, Arkema, EV

Get full text

Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden by Eriksson, Jonas K, Neovius, Martin, Jacobson, Stefan H, Elinder, Carl-Gustaf, Hylander, Britta

“…ObjectiveTo compare healthcare costs in chronic kidney disease (CKD) stage 4 or 5 not on dialysis (estimated glomerular filtration rate <30 mL/min/1.73m2),…”
Get full text

Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden by Hellgren, K., Smedby, K. E., Backlin, C., Sundstrom, C., Feltelius, N., Eriksson, J. K., Baecklund, E., Askling, J.

“…Objective Data on lymphoma risk in ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are scarce. This study was undertaken to assess the risk of…”
Get full text

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study by Exarchou, Sofia, Lindström, Ulf, Askling, Johan, Eriksson, Jonas K, Forsblad-d'Elia, Helena, Neovius, Martin, Turesson, Carl, Kristensen, Lars Erik, Jacobsson, Lennart T H

“…Prevalence estimates of ankylosing spondylitis vary considerably, and there are few nationwide estimates. The present study aimed to describe the national…”
Get full text

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial by Eriksson, Jonas K, Karlsson, Johan A, Bratt, Johan, Petersson, Ingemar F, van Vollenhoven, Ronald F, Ernestam, Sofia, Geborek, Pierre, Neovius, Martin

“…To estimate the incremental cost-effectiveness of infliximab versus conventional combination treatment over 21 months in patients with methotrexate-refractory…”
Get more information

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study by Neovius, Martin, Jacobson, Stefan H, Eriksson, Jonas K, Elinder, Carl-Gustaf, Hylander, Britta

“…Objective To compare mortality in chronic kidney disease (CKD) stages 4 and 5 (estimated glomerular filtration rate <30 mL/min/1.73 m2), peritoneal dialysis,…”
Get full text

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? by Wadström, H, Eriksson, JK, Neovius, M, Askling, J, on behalf of the ARTIS Study Group

“…Objectives: To assess the coverage of the Swedish Biologics Register (Anti-Rheumatic Therapy in Sweden, ARTIS) across indications, and the accuracy of the…”
Get full text

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work? by Olofsson, T, Petersson, I F, Eriksson, J K, Englund, M, Nilsson, J A, Geborek, P, Jacobsson, L T H, Askling, J, Neovius, M

“…To examine predictors of work ability gain and loss after anti-tumour necrosis factor (TNF) start, respectively, in working-age patients with rheumatoid…”
Get more information

Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study by Keating, Catherine, PhD, Neovius, Martin, Dr, Sjöholm, Kajsa, PhD, Peltonen, Markku, PhD, Narbro, Kristina, PhD, Eriksson, Jonas K, PhD, Sjöström, Lars, PhD, Carlsson, Lena M S, PhD

“…Summary Background Bariatric surgery prevents and induces remission of type 2 diabetes in many patients. The effect of preoperative glucose status on long-term…”
Get full text

Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden by Wallman, Johan K, Eriksson, Jonas K, Nilsson, Jan-Åke, Olofsson, Tor, Kristensen, Lars-Erik, Neovius, Martin, Geborek, Pierre

“…To compare how costs relate to disability, disease activity, and health-related quality of life (HRQOL) in rheumatoid arthritis (RA). Antitumor necrosis factor…”
Get full text

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort by Olofsson, Tor, Petersson, Ingemar F, Eriksson, Jonas K, Englund, Martin, Simard, Julia F, Nilsson, Jan-Åke, Geborek, Pierre, Jacobsson, Lennart T H, Askling, Johan, Neovius, Martin

“…To identify predictors of sick leave and disability pension in patients with early rheumatoid arthritis (RA). Individuals aged 19-59 years diagnosed with early…”
Get more information

Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial by Eriksson, Jonas K, Neovius, Martin, Bratt, Johan, Petersson, Ingemar F, van Vollenhoven, Ronald F, Geborek, Pierre, Ernestam, Sofia

“…The introduction of biological tumor necrosis factor inhibitors has improved the treatment of rheumatoid arthritis (RA) but at a substantial cost. These drugs…”
Get more information

Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register by Lindström, U, Exarchou, S, Sigurdardottir, V, Sundström, B, Askling, J, Eriksson, JK, Forsblad-d'Elia, H, Turesson, C, Kristensen, LE, Jacobsson, L

“…Objectives: Epidemiological studies of spondyloarthritis (SpA), using ICD codes from the Swedish National Patient Register (NPR), offer unique possibilities…”
Get full text